Baxion
Screening
Tags
Alerts
Theme
Myriad Genetics Inc.
MYGN
·
NASDAQ
·
$3.85
Share Price as of 11/2
·
$364M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
07/31/26
10-Q
Q1 ended 03/31/26
05/06/26
10-K
FY 2025
02/24/26
10-Q
Q3 ended 09/30/25
11/04/25
10-Q
Q2 ended 06/30/25
08/06/25
Disclosures
Filter
8-K
Current report
10/20/26
8-K
Change in Directors or Officers
10/09/26
8-K
Change in Directors or Officers; Regulation FD Disclosure
09/16/26
8-K
Results of Operations
07/30/26
8-K
Change in Directors or Officers
06/23/26
Prospectuses and Registrations
Filter
S-8
Registration of securities for employees
06/04/26
S-8
Registration of securities for employees
06/04/26
424B3
Prospectus
03/04/26
S-3
Shelf registration
02/24/26
S-8
Registration of securities for employees
06/05/25
Proxies
Filter
DEF 14A
Definitive proxy
04/14/26
DEFA14A
Additional proxy materials
04/14/26
DEF 14A
Definitive proxy
04/09/25
DEFA14A
Additional proxy materials
04/09/25
DEF 14A
Definitive proxy
04/17/24
Ownership
Filter
SC 13G/A
Beneficial ownership (amended)
10/27/26
Form 4
Insider transaction
09/22/26
Form 4
Insider transaction
09/18/26
Form 3
Initial insider ownership
09/17/26
Form 4
Insider transaction
09/17/26
Other
Filter
ARS
Annual report to shareholders
04/14/26
EFFECT
Request for effectiveness
03/04/26
CORRESP
Correspondence with the SEC
03/02/26
UPLOAD
Letter from the SEC
02/27/26
ARS
Annual report to shareholders
04/09/25
Latest Filings
Filter
8-K
Current report
10/20/26
8-K
Change in Directors or Officers
10/09/26
8-K
Change in Directors or Officers; Regulation FD Disclosure
09/16/26
10-Q
Q2 ended 06/30/26
07/31/26
8-K
Results of Operations
07/30/26
Ownership
Filter
SC 13G/A
Beneficial ownership (amended)
10/27/26
Form 4
Insider transaction
09/22/26
Form 4
Insider transaction
09/18/26
Form 3
Initial insider ownership
09/17/26
Form 4
Insider transaction
09/17/26